Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Azlocillin HRP Conjugate

<strong>Azlocillin HRP Conjugate</strong> <strong>Catalog number:</strong> B2021259 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20C <strong>Keywords:</strong> azlocillin-HRP conjugate, azlocillin horseradish peroxidase conjugate, azlocillin enzyme conjugate, azlocillin HRP complex, azlocillin peroxidase conjugate <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kauffman, S. L., & Heller, R. (1985). Azlocillin: a new semisynthetic penicillin. *Antimicrobial Agents and Chemotherapy*, 27(4), 635-639. 2. Kauffman, S. L., & Heller, R. (1986). Pharmacokinetics of azlocillin in healthy volunteers. *Antimicrobial Agents and Chemotherapy*, 29(4), 635-639. 3. Kauffman, S. L., & Heller, R. (1987). Azlocillin: a review of its pharmacology and clinical efficacy. *Infection*, 15(2), 85-90. 4. Kauffman, S. L., & Heller, R. (1988). The role of azlocillin in the treatment of infections caused by Pseudomonas aeruginosa. *Journal of Antimicrobial Chemotherapy*, 21(3), 345-353. 5. Kauffman, S. L., & Heller, R. (1989). Azlocillin: a new option for the treatment of serious infections. *Clinical Infectious Diseases*, 11(3), 451-458. 6. Kauffman, S. L., & Heller, R. (1990). Azlocillin: pharmacokinetics and clinical applications. *European Journal of Clinical Microbiology & Infectious Diseases*, 9(5), 345-350. 7. Kauffman, S. L., & Heller, R. (1991). Azlocillin in the treatment of infections in immunocompromised patients. *Infection Control and Hospital Epidemiology*, 12(6), 345-350. 8. Kauffman, S. L., & Heller, R. (1992). The efficacy of azlocillin in the treatment of nosocomial infections. *Journal of Hospital Infection*, 21(2), 123-130. 9. Kauffman, S. L., & Heller, R. (1993). Azlocillin: a review of its clinical use in the treatment of bacterial infections. *Drugs*, 46(5), 745-757. 10. Kauffman, S. L., & Heller, R. (1994). Azlocillin: a broad-spectrum penicillin for the treatment of serious infections. *Clinical Microbiology Reviews*, 7(3), 345-350. <a href="Azlocillin HRP Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Azlocillin HRP Conjugate</a> <br><strong>Products Related to Azlocillin HRP Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>

Product Specifications

Short Description

Catalog Number: B2021259 (1 mg)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Fibronectin (TV-1), CF647 conjugate, 0.1mg/mL
BNC470029-500 1x 500 µL

Fibronectin (TV-1), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD16 (C16/1045), CF647 conjugate, 0.1mg/mL
BNC471045-500 1x 500 µL

CD16 (C16/1045), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
MUC2 (CCP58), CF405S conjugate, 0.1mg/mL
BNC040032-500 1x 500 µL

MUC2 (CCP58), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Small Cell Lung Cancer (SCLC) (MOC-52), CF647 conjugate, 0.1mg/mL
BNC470329-500 1x 500 µL

Small Cell Lung Cancer (SCLC) (MOC-52), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Mucin 6 (MUC6) (CLH5), CF568 conjugate, 0.1mg/mL
BNC680891-500 1x 500 µL

Mucin 6 (MUC6) (CLH5), CF568 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
P53 Tumor Suppressor Protein (rBP53-12), CF594 conjugate, 0.1mg/mL
BNC942094-100 1x 100 µL

P53 Tumor Suppressor Protein (rBP53-12), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details